AKAP12 and colorectal carcinoma: The expression of AKAP12 has been verified to be decreased in multiple cancers, including hepatocellular carcinoma (HCC) (Lee et al., 2018), CRC (He et al., 2018), and breast cancer (Soh et al., 2018).